drugset / Trial / NCT02187094

Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis

NCT02187094 ↗

Phase 1/2 Completed 80 enrolled Targacept Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

Gastroparesis, also referred to as delayed gastric emptying, is a debilitating, chronic disorder that slows or stops the passage of food from the stomach to the small intestine. The purpose of this study is to test whether TC-6499 is safe and effective at reducing gastric emptying time in diabetic subjects with gastroparesis.

Timeline

Start
2014-06
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject simpinicline Small molecule 2 mg —
Subject simpinicline Small molecule 5 mg —
Subject simpinicline Small molecule 10 mg —

Indications